5v9j - Revision history

OCA at 13:44, 4 October 2023

OCA — Wed, 04 Oct 2023 13:44:19 GMT

←Older revision		Revision as of 13:44, 4 October 2023
Line 3:		Line 3:
	<StructureSection load='5v9j' size='340' side='right'caption='[[5v9j]], [[Resolution\|resolution]] 1.74Å' scene=''>		<StructureSection load='5v9j' size='340' side='right'caption='[[5v9j]], [[Resolution\|resolution]] 1.74Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5v9j]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5V9J OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=5V9J FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5v9j]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5V9J OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5V9J FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=90P:N~2~-cyclohexyl-N~4~-(1-ethylpiperidin-4-yl)-6,7-dimethoxy-N~2~-methylquinazoline-2,4-diamine'>90P</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=SAM:S-ADENOSYLMETHIONINE'>SAM</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>~~</td></tr>~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.74Å</td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5v9i\|5v9i]]~~</td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=90P:N~2~-cyclohexyl-N~4~-(1-ethylpiperidin-4-yl)-6,7-dimethoxy-N~2~-methylquinazoline-2,4-diamine'>90P</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=SAM:S-ADENOSYLMETHIONINE'>SAM</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=5v9j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5v9j OCA], [~~http~~://pdbe.org/5v9j PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5v9j RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5v9j PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5v9j ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5v9j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5v9j OCA], [https://pdbe.org/5v9j PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5v9j RCSB], [https://www.ebi.ac.uk/pdbsum/5v9j PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5v9j ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN]] Defects in EHMT1 are the cause of chromosome 9q subtelomeric deletion syndrome (9q- syndrome) [MIM:[~~http~~://omim.org/entry/610253 610253]]. Common features seen in these patients are severe mental retardation, hypotonia, brachy(micro)cephaly, epileptic seizures, flat face with hypertelorism, synophrys, anteverted nares, cupid bow or tented upper lip, everted lower lip, prognathism, macroglossia, conotruncal heart defects, and behavioral problems.	+	[https://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN] Defects in EHMT1 are the cause of chromosome 9q subtelomeric deletion syndrome (9q- syndrome) [MIM:[https://omim.org/entry/610253 610253]. Common features seen in these patients are severe mental retardation, hypotonia, brachy(micro)cephaly, epileptic seizures, flat face with hypertelorism, synophrys, anteverted nares, cupid bow or tented upper lip, everted lower lip, prognathism, macroglossia, conotruncal heart defects, and behavioral problems.
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN]] Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53.<ref>PMID:12004135</ref> <ref>PMID:20118233</ref>	+	[https://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN] Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53.<ref>PMID:12004135</ref> <ref>PMID:20118233</ref>

	==See Also==		==See Also==
Line 19:		Line 19:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Arrowsmith~~, C H~~]]	+	[[Category: Arrowsmith CH]]
-	[[Category: Babault, N]]	+	[[Category: Babault N]]
-	[[Category: Bountra, C]]	+	[[Category: Bountra C]]
-	[[Category: Brown~~, P J~~]]	+	[[Category: Brown PJ]]
-	[[Category: Dong, A]]	+	[[Category: Dong A]]
-	[[Category: Edwards~~, A M~~]]	+	[[Category: Edwards AM]]
-	[[Category: Jin, J]]	+	[[Category: Jin J]]
-	[[Category: Liu, J]]	+	[[Category: Liu J]]
-	~~[[Category: Structural genomic~~]]	+	[[Category: Tempel W]]
-	[[Category: Tempel, W]]	+	[[Category: Wu H]]
-	[[Category: Wu, H]]	+	[[Category: Xiong Y]]
-	[[Category: Xiong, Y]]	+	[[Category: Zeng H]]
-	[[Category: Zeng, H]]	+
-	~~[[Category: Ehmt1]]~~	+
-	~~[[Category: Methyltransferase]]~~	+
-	~~[[Category: Sgc]]~~	+
-	~~[[Category: Transferase~~]]	+

OCA at 08:32, 30 September 2020

OCA — Wed, 30 Sep 2020 08:32:54 GMT

←Older revision		Revision as of 08:32, 30 September 2020
Line 1:		Line 1:

	==Crystal structure of catalytic domain of GLP with MS0105==		==Crystal structure of catalytic domain of GLP with MS0105==
-	<StructureSection load='5v9j' size='340' side='right' caption='[[5v9j]], [[Resolution\|resolution]] 1.74Å' scene=''>	+	<StructureSection load='5v9j' size='340' side='right'caption='[[5v9j]], [[Resolution\|resolution]] 1.74Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5v9j]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5V9J OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5V9J FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5v9j]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5V9J OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5V9J FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=90P:N~2~-cyclohexyl-N~4~-(1-ethylpiperidin-4-yl)-6,7-dimethoxy-N~2~-methylquinazoline-2,4-diamine'>90P</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=SAM:S-ADENOSYLMETHIONINE'>SAM</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=90P:N~2~-cyclohexyl-N~4~-(1-ethylpiperidin-4-yl)-6,7-dimethoxy-N~2~-methylquinazoline-2,4-diamine'>90P</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=SAM:S-ADENOSYLMETHIONINE'>SAM</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5v9i\|5v9i]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5v9i\|5v9i]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5v9j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5v9j OCA], [http://pdbe.org/5v9j PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5v9j RCSB], [http://www.ebi.ac.uk/pdbsum/5v9j PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5v9j ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5v9j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5v9j OCA], [http://pdbe.org/5v9j PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5v9j RCSB], [http://www.ebi.ac.uk/pdbsum/5v9j PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5v9j ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 12:		Line 12:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN]] Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53.<ref>PMID:12004135</ref> <ref>PMID:20118233</ref>		[[http://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN]] Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53.<ref>PMID:12004135</ref> <ref>PMID:20118233</ref>
		+
		+	==See Also==
		+	*[[Histone methyltransferase 3D structures\|Histone methyltransferase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Arrowsmith, C H]]		[[Category: Arrowsmith, C H]]
	[[Category: Babault, N]]		[[Category: Babault, N]]

OCA at 07:32, 21 March 2018

OCA — Wed, 21 Mar 2018 07:32:38 GMT

←Older revision		Revision as of 07:32, 21 March 2018
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5v9j is ~~ON HOLD until Paper Publication~~	+	==Crystal structure of catalytic domain of GLP with MS0105==
-		+	<StructureSection load='5v9j' size='340' side='right' caption='[[5v9j]], [[Resolution\|resolution]] 1.74Å' scene=''>
-	~~Authors~~: ~~Dong~~, A., ~~Zeng~~, H., ~~Liu~~, J., ~~Xiong~~, Y., ~~Babault~~, N., ~~Jin~~, J., ~~Tempel~~, W., ~~Bountra~~, C., ~~Arrowsmith~~, C.H., ~~Edwards, A~~.M., Wu, H., ~~Brown~~, P.J., ~~Structural Genomics Consortium (SGC)~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[5v9j]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5V9J OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5V9J FirstGlance]. <br>
-	~~Description~~: ~~Crystal structure~~ of ~~catalytic domain~~ of ~~GLP with MS0105~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=90P:N~2~-cyclohexyl-N~4~-(1-ethylpiperidin-4-yl)-6,7-dimethoxy-N~2~-methylquinazoline-2,4-diamine'>90P</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=SAM:S-ADENOSYLMETHIONINE'>SAM</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5v9i\|5v9i]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5v9j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5v9j OCA], [http://pdbe.org/5v9j PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5v9j RCSB], [http://www.ebi.ac.uk/pdbsum/5v9j PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5v9j ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN]] Defects in EHMT1 are the cause of chromosome 9q subtelomeric deletion syndrome (9q- syndrome) [MIM:[http://omim.org/entry/610253 610253]]. Common features seen in these patients are severe mental retardation, hypotonia, brachy(micro)cephaly, epileptic seizures, flat face with hypertelorism, synophrys, anteverted nares, cupid bow or tented upper lip, everted lower lip, prognathism, macroglossia, conotruncal heart defects, and behavioral problems.
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/EHMT1_HUMAN EHMT1_HUMAN]] Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53.<ref>PMID:12004135</ref> <ref>PMID:20118233</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Arrowsmith, C H]]
		+	[[Category: Babault, N]]
		+	[[Category: Bountra, C]]
		+	[[Category: Brown, P J]]
	[[Category: Dong, A]]		[[Category: Dong, A]]
-	[[Category: ~~Zeng~~, H]]	+	[[Category: Edwards, A M]]
-	[[Category: ~~Babault~~, N]]	+	[[Category: Jin, J]]
	[[Category: Liu, J]]		[[Category: Liu, J]]
		+	[[Category: Structural genomic]]
		+	[[Category: Tempel, W]]
	[[Category: Wu, H]]		[[Category: Wu, H]]
-	[[Category: Jin, J]]
-	[[Category: Bountra, C]]
-	[[Category: Tempel, W]]
-	[[Category: Arrowsmith, C.H]]
-	[[Category: Brown, P.J]]
	[[Category: Xiong, Y]]		[[Category: Xiong, Y]]
-	[[Category: ~~Edwards~~, ~~A.M~~]]	+	[[Category: Zeng, H]]
-	[[Category: ~~Structural Genomics Consortium (~~Sgc)]]	+	[[Category: Ehmt1]]
		+	[[Category: Methyltransferase]]
		+	[[Category: Sgc]]
		+	[[Category: Transferase]]

OCA at 13:57, 27 September 2017

OCA — Wed, 27 Sep 2017 13:57:10 GMT

←Older revision		Revision as of 13:57, 27 September 2017
Line 5:		Line 5:
	Authors: Dong, A., Zeng, H., Liu, J., Xiong, Y., Babault, N., Jin, J., Tempel, W., Bountra, C., Arrowsmith, C.H., Edwards, A.M., Wu, H., Brown, P.J., Structural Genomics Consortium (SGC)		Authors: Dong, A., Zeng, H., Liu, J., Xiong, Y., Babault, N., Jin, J., Tempel, W., Bountra, C., Arrowsmith, C.H., Edwards, A.M., Wu, H., Brown, P.J., Structural Genomics Consortium (SGC)

-	Description: Crystal structure of catalytic domain of GLP with ~~UNC3644~~	+	Description: Crystal structure of catalytic domain of GLP with MS0105
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
-	[[Category: Arrowsmith, C.H]]
	[[Category: Dong, A]]		[[Category: Dong, A]]
-	[[Category: Brown, P.J]]
	[[Category: Zeng, H]]		[[Category: Zeng, H]]
-	[[Category: Xiong, Y]]
	[[Category: Babault, N]]		[[Category: Babault, N]]
-	[[Category: Edwards, A.M]]
-	[[Category: Structural Genomics Consortium (Sgc)]]
	[[Category: Liu, J]]		[[Category: Liu, J]]
	[[Category: Wu, H]]		[[Category: Wu, H]]
Line 20:		Line 15:
	[[Category: Bountra, C]]		[[Category: Bountra, C]]
	[[Category: Tempel, W]]		[[Category: Tempel, W]]
		+	[[Category: Arrowsmith, C.H]]
		+	[[Category: Brown, P.J]]
		+	[[Category: Xiong, Y]]
		+	[[Category: Edwards, A.M]]
		+	[[Category: Structural Genomics Consortium (Sgc)]]

OCA at 13:40, 17 May 2017

OCA — Wed, 17 May 2017 13:40:53 GMT

←Older revision		Revision as of 13:40, 17 May 2017
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5v9j is ON HOLD	+	The entry 5v9j is ON HOLD until Paper Publication

	Authors: Dong, A., Zeng, H., Liu, J., Xiong, Y., Babault, N., Jin, J., Tempel, W., Bountra, C., Arrowsmith, C.H., Edwards, A.M., Wu, H., Brown, P.J., Structural Genomics Consortium (SGC)		Authors: Dong, A., Zeng, H., Liu, J., Xiong, Y., Babault, N., Jin, J., Tempel, W., Bountra, C., Arrowsmith, C.H., Edwards, A.M., Wu, H., Brown, P.J., Structural Genomics Consortium (SGC)

OCA: Protected "5v9j" [edit=sysop:move=sysop]

OCA — Wed, 05 Apr 2017 11:49:54 GMT

Protected "5v9j" [edit=sysop:move=sysop]

←Older revision

Revision as of 11:49, 5 April 2017

OCA: New page: '''Unreleased structure''' The entry 5v9j is ON HOLD Authors: Dong, A., Zeng, H., Liu, J., Xiong, Y., Babault, N., Jin, J., Tempel, W., Bountra, C., Arrowsmith, C.H., Edwards, A.M., Wu,...

OCA — Wed, 05 Apr 2017 11:49:53 GMT

New page: '''Unreleased structure''' The entry 5v9j is ON HOLD Authors: Dong, A., Zeng, H., Liu, J., Xiong, Y., Babault, N., Jin, J., Tempel, W., Bountra, C., Arrowsmith, C.H., Edwards, A.M., Wu,...

New page

'''Unreleased structure'''

The entry 5v9j is ON HOLD

Authors: Dong, A., Zeng, H., Liu, J., Xiong, Y., Babault, N., Jin, J., Tempel, W., Bountra, C., Arrowsmith, C.H., Edwards, A.M., Wu, H., Brown, P.J., Structural Genomics Consortium (SGC)

Description: Crystal structure of catalytic domain of GLP with UNC3644
[[Category: Unreleased Structures]]
[[Category: Arrowsmith, C.H]]
[[Category: Dong, A]]
[[Category: Brown, P.J]]
[[Category: Zeng, H]]
[[Category: Xiong, Y]]
[[Category: Babault, N]]
[[Category: Edwards, A.M]]
[[Category: Structural Genomics Consortium (Sgc)]]
[[Category: Liu, J]]
[[Category: Wu, H]]
[[Category: Jin, J]]
[[Category: Bountra, C]]
[[Category: Tempel, W]]